iMBIORAY

Hangzhou, China · Founded 2014 · Privately Held (backing)

Developer of innovative drugs intended for the treatment of tumors and immune diseases. iMBIORAY is based in Hangzhou, China and was founded in 2014. It has raised $90.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$90.9M
Last round
—

Who backs iMBIORAY?

15 investors
InvestorType
Lapam CapitalVenture capital
Tailong VCOther
South China Venture CapitalOther
Hangzhou Hi-Tech Financial Investment GroupOther
Huayi CapitalVenture capital
Beijing Zhongguancun Venture Capital DevelopmentOther
Honghui CapitalVenture capital
Zhejiang Zheda Qizhen Venture CapitalOther
Beiyu Capital—
Deep Intelligent Pharma—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

iMBIORAY investors

Free account
More of iMBIORAY with a free account
  • ·The complete investor list: 15 names
  • ·Watch iMBIORAY: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like iMBIORAY. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View